{"DataElement":{"publicId":"2320025","version":"1","preferredName":"Core Biopsy Prostate Gland Malignant Neoplasm Performed Count","preferredDefinition":"the number of core biopsy samples taken from the prostate that were determined to malignant.","longName":"COR_PRS_MAL_PER_CT","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2760125","version":"1","preferredName":"Core Biopsy Prostate Gland Malignant Neoplasm Performed","preferredDefinition":"information related to the removal of a tissue sample of abnormal and uncontrolled cell growth located in the prostate gland, a gland of the male reproductive system just below the bladder, using a needle with a relatively large diameter, for microscopic examination and determined to be malignant, a tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.","longName":"COREBX_PRST_MAL_PERF","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2483548","version":"1","preferredName":"Core Biopsy","preferredDefinition":"The removal of a tissue sample with a needle for examination under a microscope.","longName":"C15680","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Core Biopsy","conceptCode":"C15680","definition":"The removal of a tissue sample using a needle with a relatively large diameter, for microscopic examination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"148B6A47-AA7F-5290-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-24","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-05-24","modifiedBy":"ONEDATA","dateModified":"2006-05-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2760123","version":"1","preferredName":"Prostate Malignant Neoplasm Performed","preferredDefinition":"A gland in the male reproductive system just below the bladder. It surrounds part of the urethra, the canal that empties the bladder. It produces a fluid that forms part of semen. (NCI-GLOSS):A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004:Performed; carried out.","longName":"C12410:C9305:C38000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Gland","conceptCode":"C12410","definition":"The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Performed","conceptCode":"C38000","definition":"Executed and carried through to completion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4FF4D371-01C8-3A7E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-18","modifiedBy":"ONEDATA","dateModified":"2008-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4FF4D371-01D9-3A7E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-25","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-18","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018392","version":"1","preferredName":"Count","preferredDefinition":"The quantity of the specified item.","longName":"CT","context":"NCI Standards","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":"1","maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":"0","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008541","version":"1","preferredName":"Numbers","preferredDefinition":"the set of non-negative integers.","longName":"NUMS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B227CE66-2830-4A7B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2261845","version":"1","preferredName":"Count","preferredDefinition":"To determine the number or amount of something; the result of this activity.","longName":"C25463","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Count","conceptCode":"C25463","definition":"Determining the number or amount of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"FBB87F7A-646B-1AFC-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-13","modifiedBy":"ONEDATA","dateModified":"2005-07-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B3BF4389-4489-5F2C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-09","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-01-08","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/11/17 tt transferred context, added reg status and CSI per Round 5 finalization task.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811910","version":"1","longName":"Prostate","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"}]},{"publicId":"3896529","version":"1","longName":"Consortia 2012 Studies","context":"DCP","ClassificationSchemeItems":[{"publicId":"4528055","version":"1","longName":"UAZ2014-03-01","context":"DCP"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4171065","version":"1","longName":"RTOG-0924","context":"NRG"},{"publicId":"4171064","version":"1","longName":"RTOG-0815","context":"NRG"}]}],"AlternateNames":[{"name":"DCI","type":"USED_BY","context":"DCI"},{"name":"COR_PRS_MAL_PER_CT","type":"USED_BY","context":"NRG"},{"name":"DCP","type":"USED_BY","context":"DCP"},{"name":"MI_MIORRES_POSITIVE_CORES","type":"OID, CCTG","context":"CCTG"},{"name":"NUM_POS_BIO_CORE","type":"DCP Alt Name","context":"DCP"}],"ReferenceDocuments":[{"name":"CRF Text","type":"Preferred Question Text","description":"Number of positive core biopsies","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Number cores positive","url":null,"context":"CTEP"},{"name":"DCP CRF Text 1","type":"Alternate Question Text","description":"Number of Positive Cores","url":null,"context":"DCP"},{"name":"CCTG_01","type":"Alternate Question Text","description":"Number of positive cores","url":null,"context":"CCTG"},{"name":"DCP-Text-2","type":"Alternate Question Text","description":"Number of Biopsy Cores Positive for Cancer","url":null,"context":"DCP"}],"origin":"RTOG CRF:Radiation Therapy Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FCBA418C-3113-736B-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-25","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-07-25","modifiedBy":"MMADDINENI","dateModified":"2024-01-15","changeDescription":null,"administrativeNotes":"11/16/23 Added alt OID and AQT for CCTG ticket number CADSR0003085 cjl.","unresolvedIssues":null,"deletedIndicator":"No"}}